Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9917156 | 0.99 | CRHR1 (0.30) | CRHR1 | |
| SCHEMBL13871940 | 0.97 | — | — | |
| SCHEMBL13433379 | 0.97 | CRHR1 (0.32) | CRHR1 | |
| SCHEMBL12701571 | 0.92 | CRHR1 (0.32) | CRHR1 | |
| SCHEMBL14495609 | 0.91 | CRHR1 (0.34) | CRHR1 | |
| SCHEMBL13588257 | 0.90 | CRHR1 (0.33) | CRHR1 | |
| SCHEMBL13688602 | 0.90 | CRHR1 (0.36) | CRHR1 | |
| SCHEMBL13531443 | 0.87 | CRHR1 (0.31) | CRHR1 | |
| SCHEMBL19829444 | 0.87 | CRHR1 (0.36) | CRHR1 | |
| SCHEMBL13531438 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9546261-B2 | Stabilizing of organic material with amino-triazine based mannich-compounds | BOREALIS AG (AT) | 2017-01-17 | — | — | US | disclosed |
| US-20140235766-A1 | Stabilizing of Organic Material with Amino-Triazine Based Mannich-Compounds | BOREALIS AG (AT) | 2014-08-21 | — | — | US | disclosed |
| US-20110092632-A1 | POROUS INORGANIC MATERIALS CONTAINING POLYMER ADDITIVES | BRAND FABIEN JEAN | 2011-04-21 | — | — | US | disclosed |
| US-7884147-B2 | Of specific high-molecular-weight polyalkylpiperidine derivatives; stabilizing polyolefins against thermal, oxidative or light-induced degradation | BASF SE (DE) | 2011-02-08 | — | — | US | disclosed |
| US-20100048773-A1 | AGRICULTURAL ARTICLES | BONORA MICHELA | 2010-02-25 | — | — | US | disclosed |
| US-20090312464-A1 | Stabilizer mixtures | GUGUMUS FRANCOIS | 2009-12-17 | — | — | US | disclosed |
| US-7628936-B2 | Mixture of steric hindred amine compound with magnesium and zinc salt; photostability; heat and oxidation resistance; for polymers | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2009-12-08 | — | — | US | disclosed |
| US-7595008-B2 | Mixture containing steric hindred amine compound with zinc and magnesium salt; photostability; heat and oxidation resistance; for polymers | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2009-09-29 | — | — | US | disclosed |
| US-20090111917-A1 | Stabilized articles | BONORA MICHELA | 2009-04-30 | — | — | US | disclosed |
| US-20080058459-A1 | Porous Inorganic Materials Containing Polymer Additives | CIBA CORP. | 2008-03-06 | — | — | US | disclosed |
| US-7332105-B2 | Synergistic UV absorber combination | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2008-02-19 | — | — | US | disclosed |
| US-20070135537-A1 | Agricultural articles | BONORA MICHAEL | 2007-06-14 | — | — | US | disclosed |
| US-7169835-B2 | Stabilizer mixture | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140235766-A1 | Stabilizing of Organic Material with Amino-Triazine Based Mannich-Compounds | PCNA, SOD1, UBE2M | CRHR1 3179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.